TLE1 and type 2 diabetes mellitus: In T2DM rats, GRg1 can reduce blood glucose, improve IR, and regulate lipid metabolism indicators (including TCHO, TG, LDL-C), while exhibiting hepatic protection and improving T2DM-related pathological indicators [207].